An exploratory study of a product in Sienna Biopharmaceuticals’ Topical By Design platform showed modest results for psoriasis patients who used the therapy for 10 days. Subjects who applied the topical medication as part of the 15-person, double-blind study did not see a significant reduction in inflammation, but the test did show a “modulation” of…
Print
Email
